- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Top 5 AJMC® Articles of November 2019
Here are the top 5 articles for the month of November.
Hi, this is Laura Joszt for The American Journal of Managed Care®. Here are the top 5 articles for the month of November.
Number 5: Data presented at the 2019 American Heart Association Scientific Sessions may have answered how a purified fish oil pill reduces cardiovascular events. The research suggests the pill helps slow the advance of various coronary plaques.
Number 4: At the American Society of Nephrology's Kidney Week 2019 investigators presented data about 3 phase 3 trials of roxadustat. The trials showed promising results about the first-in-class oral drug to treat chronic kidney disease in patients with anemia.
Number 3: First Stop Health’s inaugural 2019 Health Benefits Cost Containment Report found that reigning in benefits spending is a top priority for employers, but many lack the data necessary to make effective changes.
Number 2: Results from ISCHEMIA, presented at the American Heart Association Scientific Sessions, showed invasive procedures like stents are often no better than medical therapy and lifestyle changes at preventing a heart attack in patients with stable heart disease.
Number 1: CMS has launched the process to craft what will come after the Oncology Care Model, the 5-year alternative payment model that ends in 2021. The successor, Oncology Care First, would include a prospective, monthly population payment; accountability for total costs of care incurred over a 6-month episode; changes to make attribution more predictable, and electronic patient-reported outcomes.
To read all of these articles and more, visit ajmc.com.
Patients With MG Report Higher Azathioprine Discontinuation vs Other Immunosuppressants
May 15th 2024Survey data from over 200 patients showed that treatment discontinuation was lower for those taking mycophenolate or methotrexate than for those taking azathioprine for their myasthenia gravis (MG).
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
